Latest AI and machine learning research in chemotherapy for healthcare professionals.
OBJECTIVES: Identifying patients at risk of chemoresistant osteosarcoma enables risk-adapted management. This study aimed to predict chemoresistant osteosarcoma using baseline clinical and magnetic resonance (MRI)-derived radiomics features, with histological response as the reference standard and external validation included. MATERIALS AND METHODS: This retrospective single-center study included ...
INTRODUCTION: The head-up tilt table test (HUTT) is a lengthy and uncomfortable procedure for patients which often induces fainting. Post-transient loss of consciousness, nausea, vomiting, and pallor may occur. This study aims to develop and evaluate the efficacy of anomaly detection methods based on autoencoding for early prediction of syncope onset, enabling preemptive HUTT termination and there...
BACKGROUND: Minimally invasive biomarkers predicting immunotherapy response in head and neck squamous cell carcinoma (HNSCC) remain an unmet clinical ...
BACKGROUND: Perforation following chemotherapy in gastrointestinal lymphoma (PFCGL) is a rare but severe and life-threatening complication. Early pre-...
BACKGROUND: Neoadjuvant chemotherapy (NAC) is a critical therapeutic strategy for locally advanced breast cancer; however, its clinical utility is con...
OBJECTIVE: To explore administrators' and clinicians' views on the factors that influence their use and adoption of a machine learning clinical decisi...
Neoadjuvant chemotherapy is a standard clinical practice for tumor downsizing in breast cancer, with [Formula: see text]F-FDG Positron Emission Tomogr...
Accurate identification of pathological complete response (pCR) following neoadjuvant chemoradiotherapy for locally advanced rectal cancer (LARC) is c...
Rare earth elements (REEs) are emerging contaminants with escalating environmental releases. However, REE health risk assessment faces critical challe...
BACKGROUND: The overuse of antibiotics in both veterinary and human medicine has resulted in the emergence of antibiotic-resistant bacteria, prompting...
Endometrial cancer incidence and mortality are rising globally, disproportionately affecting health systems facing diagnostic, therapeutic, and surviv...
BACKGROUND: Patients with rectal cancer who have a complete clinical response (cCR) to neoadjuvant chemo/radiotherapy (nCRT) may opt for organ preserv...
The assessment of tumor-infiltrating lymphocyte (TILs), together with gene expression signatures (GES), has the potential to guide personalized breast...
Predicting the clinical efficacy of Natural Killer (NK) cell immunotherapies remains challenging due to functional heterogeneity within effector popul...
Glioblastoma is a highly aggressive primary brain tumor with near-universal recurrence despite maximal safe resection followed by standard chemoradiat...
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking effective targeted therapies. Although immune checkpoint inhibitors such as pemb...
BACKGROUND: Multidisciplinary tumor boards (MDTBs) play a central role in breast cancer management by integrating imaging findings with clinical and p...
The integration of multiferroic materials into complementary metal-oxide-semiconductor (CMOS) technology presents an exciting frontier in nanoelectron...
Chronic cadmium chloride (CC) exposure is associated with diverse toxicological outcomes, yet its potential role in the pathogenesis of ankylosing spo...
The OncotypeDX 21-gene assay guides adjuvant chemotherapy decisions in early-stage, hormone receptor-positive, HER2-negative breast cancer, but cost a...